Featured Firms
Presented by BigVoodoo
The 3rd Circuit has approved a $44.5 million settlement of a consumer antitrust suit against DuPont Pharmaceuticals Co. that accused the manufacturer of issuing misleading statements about a generic anti-coagulant drug to protect sales of its drug Coumadin. The court also upheld the district court's decision to certify the case as a class action, over objections that the class failed to satisfy commonality and predominance requirements.
December 13, 2004 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS